Not a HIPAA covered entityArchitectural · enforced by data flow
OVYN does not handle PHI. All Veeva CRM data is de-identified by Demo Therapeutics before crossing the boundary — minimum cohort of 25, no patient-level records, 14 aggregate fields max. Therefore no BAA is required between Demo Therapeutics and OVYN. We are happy to sign a DPA on request.
SOC 2 Type 2 — infrastructureInherited from subprocessors
All upstream subprocessors (Anthropic, Vercel, Twilio, Turso) hold or are pursuing SOC 2 Type 2 certification. Reports available on request from each provider's trust portal.
SOC 2 Type 2 — OVYNRoadmap · 3–4 months for Type 1
OVYN as a company is not yet SOC 2 certified. We're a small studio. SOC 2 Type 1 process can be initiated within 30 days if Demo Therapeutics requires it as a deal condition; Type 2 follows after a 6-month observation window.
HITRUST-alignedAligned · not certified
We follow HITRUST-aligned data-handling practices: minimum-necessary access, encryption everywhere, audit trails, breach notification SLA. Not certified — alignment, not assessment. Common posture for boutique vendors.
FDA / OPDP compliancePre-MLR rail · standing instructions
Generation rail enforces fair-balance proximity, comparative-claim restrictions, outcome-guarantee prohibitions, off-label scope, and ISI requirements before content reaches your MLR team. Every variant is scored against your standing rules with auto-rewrite suggestions on flag.
21 CFR Part 11Veeva is the regulated layer
Part 11 governs electronic records / signatures for FDA-regulated systems. Your Veeva instance is the regulated record. OVYN sits beside it; the moment content lands in PromoMats, your Part 11 controls take over. We don't claim Part 11 compliance ourselves because the regulated record-of-truth is Veeva.